Where does Eyenovia, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Eyenovia, Inc. ranks #13,983 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Eyenovia, Inc. hold?

Eyenovia, Inc. holds 21 US utility patents granted between 2015 and 2025, spanning 15 technology areas.

What is Eyenovia, Inc.'s Innovation Score?

Eyenovia, Inc. has an Innovation Score of 47.2 out of 100 (top 19% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Eyenovia, Inc.'s patent grant rate increasing or decreasing?

Eyenovia, Inc.'s recent grant velocity is +160% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Eyenovia, Inc.'s patents?

Eyenovia, Inc.'s patents average 20.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Eyenovia, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Eyenovia, Inc.

Q: What technology areas does Eyenovia, Inc. focus on?

Eyenovia, Inc.'s top technology area is A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS) with 20 patents. Grants appear in 15 CPC subclasses total.

USPTO PatentsView assignee record - 21 granted patents across 15 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Eyenovia ranks #13,983 of 50,000 tracked US assignees by granted-patent volume, with 21 patents across 15 technology areas.

#13,983
of 50,000 US assignees by volume: Top 19%
by Innovation Score (47.2/100): 20.2
avg claims per patent: +160%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R13983 · US Corporation #13,983 · 21 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 21 grants
MID-PACK #13,983/50,000
PHOTO-FINISH Exabeam
CPC-FOCUS A61F · 15 areas
INNOV-PAR 47.2/100
CLAIMS-DENSE 20.2 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +160% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Exabeam, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Eyenovia · this assignee

47
3D Lighting Innovati… · lowest

7

What this shows Eyenovia, Inc. stamps GRANTS-SMALL, MID-PACK, PHOTO-FINISH, CPC-FOCUS, INNOV-PAR, CLAIMS-DENSE, TYPE-USCORP, VEL-SURGE, BOOK-FULL. Volume places it #13,983 of 50,000; Innovation Score 47.2/100 sits in the top 19% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Exabeam, Inc. (±0 grants).

Portfolio overview

Eyenovia, Inc. has been granted 21 US utility patents between 2015 and 2025, placing Eyenovia, Inc. at #13,983 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 15 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.2 claims per patent with primary concentration in A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). As a US Corporation, Eyenovia, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Eyenovia sits between Exabeam, Inc. (21 patents, rank #13,979) and Fukuda Metal FOIL & Powder Co., Ltd. (21 patents, rank #13,987) - the closest US assignees by grant volume. The composite Innovation Score of 47.2/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 13 grants, compared with 5 in the 2015–2019 window, a +160% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.

Claim depth and technology breadth describe this aggregate record. Eyenovia, Inc.'s 20.2 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 15 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.

Exabeam

21
Excelitas Canada

21
Exegy Incorporated

21
Eyepoint Pharmace…

21
Flashsilicon Inco…

21
Freevalve AB

21
FTI Consulting Te…

21
Fukuda Metal FOIL…

21
Eyenovia ◀

21

What this shows Eyenovia holds 21 patents at rank #13,983, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Eyenovia

By rank, the assignees closest to #13,983 in granted patent volume.

Leaders in A61F (Filters Implantable INTO Blood Vessels)

Other assignees with the most granted patents in Eyenovia's primary technology class.

Eyenovia's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

47 Top 19% higher than 81% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Eyenovia, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	4.8%
2016	1	4.8%
2017	1	4.8%
2018	2	9.5%
2020	3	14.3%
2021	2	9.5%
2022	3	14.3%
2023	1	4.8%
2024	4	19.0%
2025partial year	3	14.3%

Which technologies does Eyenovia, Inc. patent most?

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 20

B05B - SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES 18

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 18

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 9

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 8

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 6

G16Z - INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR 6

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 2

H10N - ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR 2

B41J - TYPEWRITERS; SELECTIVE PRINTING MECHANISMS, i.e. MECHANISMS PRINTING OTHERWISE THAN FROM A FORME; CORRECTION OF TYPOGRAPHICAL ERRORS 2

G01H - MEASUREMENT OF MECHANICAL VIBRATIONS OR ULTRASONIC, SONIC OR INFRASONIC WAVES 2

B65B - MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING 1

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 1

B06B - METHODS OR APPARATUS FOR GENERATING OR TRANSMITTING MECHANICAL VIBRATIONS OF INFRASONIC, SONIC, OR ULTRASONIC FREQUENCY, ; e.g.; FOR PERFORMING MECHANICAL WORK IN GENERAL 1

F02M - SUPPLYING COMBUSTION ENGINES IN GENERAL WITH COMBUSTIBLE MIXTURES OR CONSTITUENTS THEREOF 1

Top 15 of 15 technology areas

Where it ranks

Overall rank by patents

#13,983

of 50,000 tracked assignees

Innovation Score

47.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.